US
Europe

 

US
Europe

 

missionhistorymanagementboard of directors investors

press releasespress coverageelectronic press kit

media

 

Deutsch

 

enlarged text

 

 

 

ABOUT LUX

Lux Biosciences is a clinical stage biotechnology company specialized in the field of ophthalmic diseases. We are developing novel medications to treat the underlying causes of ophthalmic diseases and alleviate their symptoms, and if approved by regulatory authorities, we plan to commercialize these products. With two first-in-class products currently in Phase 3 clinical development and several innovative, highly promising earlier stage projects, we have made significant progress towards building a revenue-generating, high-growth and sustainable ophthalmic company.

© 2008 Lux Biosciences, Inc. All rights reserved.             Web Terms

LX201LX211LX212LX214polymer technologypipeline
other projects

uveitiscorneal transplantationdry eye syndromeage-related macular degeneration

indicationstechnologies

aboutophthalmicproducts &partnersnews &careerscontact us